Raras
Buscar doenças, sintomas, genes...
Síndrome Cockayne tipo 2
ORPHA:90322CID-10 · Q87.8CID-11 · LD2BOMIM 133540DOENÇA RARA

Síndrome de Cockayne causada por mutação(ões) no gene ERCC6, que codifica a proteína de reparo por excisão de DNA ERCC-6.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome de Cockayne causada por mutação(ões) no gene ERCC6, que codifica a proteína de reparo por excisão de DNA ERCC-6.

Publicações científicas
1.557 artigos
Último publicado: 2026 Mar 31
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
14 sintomas
👁️
Olhos
11 sintomas
😀
Face
8 sintomas
🧬
Pele e cabelo
8 sintomas
📏
Crescimento
6 sintomas
🦴
Ossos e articulações
6 sintomas

+ 34 sintomas em outras categorias

Características mais comuns

100%prev.
Atraso no desenvolvimento motor
Frequência: 3/3
100%prev.
Dorso nasal proeminente
Frequência: 3/3
100%prev.
Déficit de crescimento
Frequência: 3/3
100%prev.
Polineuropatia
Frequência: 3/3
100%prev.
Face triangular
Frequência: 3/3
100%prev.
Tecido adiposo subcutâneo reduzido
Frequência: 3/3
107sintomas
Muito frequente (16)
Frequente (13)
Ocasional (24)
Muito raro (2)
Sem dados (52)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 107 características clínicas mais associadas, ordenadas por frequência.

Atraso no desenvolvimento motorHP:0003819
Frequência: 3/3100%
Dorso nasal proeminenteProminent nasal bridge
Frequência: 3/3100%
Déficit de crescimentoFailure to thrive
Frequência: 3/3100%
PolineuropatiaPolyneuropathy
Frequência: 3/3100%
Face triangularTriangular face
Frequência: 3/3100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa5
Total histórico1.557PubMed
Últimos 10 anos200publicações
Pico202450 papers
Linha do tempo
2021Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição.

Autosomal recessive
ERCC1DNA excision repair protein ERCC-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Non-catalytic component of a structure-specific DNA repair endonuclease responsible for the 5'-incision during DNA repair. Responsible, in conjunction with SLX4, for the first step in the repair of interstrand cross-links (ICL). Participates in the processing of anaphase bridge-generating DNA structures, which consist in incompletely processed DNA lesions arising during S or G2 phase, and can result in cytokinesis failure. Also required for homology-directed repair (HDR) of DNA double-strand bre

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (5)
HDR through Single Strand Annealing (SSA)Dual incision in TC-NERDual Incision in GG-NERFormation of Incision Complex in GG-NERFanconi Anemia Pathway
MECANISMO DE DOENÇA

Cerebro-oculo-facio-skeletal syndrome 4

A disorder of prenatal onset characterized by microcephaly, congenital cataracts, facial dysmorphism, neurogenic arthrogryposis, growth failure and severe psychomotor retardation. COFS is considered to be part of the nucleotide-excision repair disorders spectrum that include also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
57.0 TPM
Cervix Endocervix
51.7 TPM
Ovário
50.5 TPM
Útero
49.6 TPM
Cervix Ectocervix
49.6 TPM
OUTRAS DOENÇAS (3)
cerebrooculofacioskeletal syndrome 4Cockayne syndrome type 2COFS syndrome
HGNC:3433UniProt:P07992
ERCC8DNA excision repair protein ERCC-8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Substrate-recognition component of the CSA complex, a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex, involved in transcription-coupled nucleotide excision repair (TC-NER), a process during which RNA polymerase II-blocking lesions are rapidly removed from the transcribed strand of active genes (PubMed:12732143, PubMed:16751180, PubMed:16964240, PubMed:32142649, PubMed:34526721, PubMed:38316879, PubMed:38600235, PubMed:38600236). Following recruitment to lesion-stalled RNA polymerase I

LOCALIZAÇÃO

NucleusChromosomeNucleus matrix

VIAS BIOLÓGICAS (5)
Formation of TC-NER Pre-Incision ComplexDual incision in TC-NERGap-filling DNA repair synthesis and ligation in TC-NERTranscription-Coupled Nucleotide Excision Repair (TC-NER)Neddylation
MECANISMO DE DOENÇA

Cockayne syndrome A

A rare disorder characterized by cutaneous sensitivity to sunlight, abnormal and slow growth, cachectic dwarfism, progeroid appearance, progressive pigmentary retinopathy and sensorineural deafness. There is delayed neural development and severe progressive neurologic degeneration resulting in intellectual disability. Two clinical forms are recognized: in the classical form or Cockayne syndrome type 1, the symptoms are progressive and typically become apparent within the first few years or life; the less common Cockayne syndrome type 2 is characterized by more severe symptoms that manifest prenatally. Cockayne syndrome shows some overlap with certain forms of xeroderma pigmentosum. Unlike xeroderma pigmentosum, patients with Cockayne syndrome do not manifest increased freckling and other pigmentation abnormalities in the skin and have no significant increase in skin cancer.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.0 TPM
Testículo
9.5 TPM
Linfócitos
8.5 TPM
Tireoide
8.0 TPM
Nervo tibial
7.0 TPM
OUTRAS DOENÇAS (5)
UV-sensitive syndrome 2Cockayne syndrome type 1Cockayne syndrome type 2UV-sensitive syndrome
HGNC:3439UniProt:Q13216
ERCC6DNA excision repair protein ERCC-6Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Essential factor involved in transcription-coupled nucleotide excision repair (TC-NER), a process during which RNA polymerase II-blocking lesions are rapidly removed from the transcribed strand of active genes (PubMed:16246722, PubMed:20541997, PubMed:22483866, PubMed:26620705, PubMed:32355176, PubMed:34526721, PubMed:38316879, PubMed:38600235, PubMed:38600236). Plays a central role in the initiation of the TC-NER process: specifically recognizes and binds RNA polymerase II stalled at a lesion,

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (7)
Formation of TC-NER Pre-Incision ComplexDual incision in TC-NERGap-filling DNA repair synthesis and ligation in TC-NERTranscription-Coupled Nucleotide Excision Repair (TC-NER)ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
MECANISMO DE DOENÇA

Cockayne syndrome B

A rare disorder characterized by cutaneous sensitivity to sunlight, abnormal and slow growth, cachectic dwarfism, progeroid appearance, progressive pigmentary retinopathy and sensorineural deafness. There is delayed neural development and severe progressive neurologic degeneration resulting in intellectual disability. Two clinical forms are recognized: in the classical form or Cockayne syndrome type 1, the symptoms are progressive and typically become apparent within the first few years or life; the less common Cockayne syndrome type 2 is characterized by more severe symptoms that manifest prenatally. Cockayne syndrome shows some overlap with certain forms of xeroderma pigmentosum. Unlike xeroderma pigmentosum, patients with Cockayne syndrome do not manifest increased freckling and other pigmentation abnormalities in the skin and have no significant increase in skin cancer.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
9.3 TPM
Fibroblastos
7.9 TPM
Skin Sun Exposed Lower leg
7.0 TPM
Tireoide
6.6 TPM
Skin Not Sun Exposed Suprapubic
6.6 TPM
OUTRAS DOENÇAS (11)
premature ovarian failure 11UV-sensitive syndrome 1de Sanctis-Cacchione syndromecerebrooculofacioskeletal syndrome 1
HGNC:3438UniProt:Q03468

Variantes genéticas (ClinVar)

745 variantes patogênicas registradas no ClinVar.

🧬 ERCC1: GRCh38/hg38 19q13.31-13.32(chr19:44626066-46268105)x3 ()
🧬 ERCC1: NM_001983.4(ERCC1):c.208G>T (p.Glu70Ter) ()
🧬 ERCC1: NM_001983.4(ERCC1):c.-7-30C>G ()
🧬 ERCC1: NM_001983.4(ERCC1):c.*441C>G ()
🧬 ERCC1: NM_001983.4(ERCC1):c.*1075C>T ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 397 variantes classificadas pelo ClinVar.

377
20
Patogênica (95.0%)
VUS (5.0%)
VARIANTES MAIS SIGNIFICATIVAS
ERCC6: NM_000124.4(ERCC6):c.3224del (p.Ala1075fs) [Likely pathogenic]
ERCC6: NM_000124.4(ERCC6):c.2874dup (p.Val959fs) [Likely pathogenic]
ERCC6: NM_001277058.2(ERCC6):c.1887C>G (p.Tyr629Ter) [Likely pathogenic]
ERCC6: NM_000124.4(ERCC6):c.319C>T (p.Gln107Ter) [Likely pathogenic]
ERCC6: NM_000124.4(ERCC6):c.547C>T (p.Gln183Ter) [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Cockayne tipo 2

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
406 papers (10 anos)
#1

A Robust Methodological Framework for Generating Whole-Brain and Cortical Organoids From Diverse Healthy- and Patient-Derived Induced Pluripotent Stem Cell Lines.

Biology of the cell2026 Feb

Patient-derived neural organoids (NOs) have emerged as powerful tools for modeling human neurodevelopmental disorders, especially when animal models are unavailable or fail to recapitulate human-specific cortical development. However, significant variability in differentiation potential, even among healthy donor lines, and especially in fragile patient-derived induced pluripotent stem cells (iPSCs), poses major methodological challenges. Protocols that succeed in one line may fail in others, leading to poor organoid formation, reduced growth, impaired neuroepithelial patterning, or complete failure to generate neural tissues. By systematically comparing multiple published protocols, we identified key sources of variability and ultimately developed optimized protocols for generating both whole-brain (WB) and cortical organoids (CO) from human iPSCs (hiPSCs), including lines from progeroid Cockayne syndrome patients. Through iterative refinement of critical parameters, including cell seeding density, Matrigel incorporation, and timing and type of pathway inhibition, we achieved consistent organoid growth and structural organization across all tested lines. The resulting pipeline is adaptable and can be further tailored for newly derived or particularly challenging hiPSC lines. Collectively, this methodological framework enables robust and reproducible generation of NOs from genetically diverse hiPSC sources, providing a reliable platform for studying human neurodevelopment and disease mechanisms in progeroid and other patient-specific contexts.

#2

ercc6 deficient zebrafish exhibit UV and metronidazole sensitivity, increased oxygen consumption, and impaired hair cell mechanoelectrical transduction which can be restored by the superoxide dismutase mimetic MnTBAP.

Human molecular genetics2026 Feb 23

Cockayne Syndrome is an ultra-rare premature aging condition associated with UV sensitivity, neurocognitive decline, retinopathy, metronidazole-induced lethality, and sensorineural hearing loss. In 70% of affected patients, bi-allelic pathogenic variants in ERCC6 are identified. Although the role of ERCC6 in DNA damage repair has been studied, little is known about the mechanism for defective ERCC6 function in clinical findings, particularly hearing loss. To identify the mechanism of disease caused by pathogenic variants in ERCC6, we developed a zebrafish (Danio rerio) ercc6 loss of function model. We assessed survival after UV and metronidazole exposure, measured basal respiration rates, and evaluated mechanoelectrical transduction function and counts of lateral line hair cells. We found that UV exposure significantly reduces ercc6-/- larval viability. Metronidazole treatment results in complete lethality; wildtype controls show nearly complete survival. ercc6-/- embryos have significantly increased oxygen consumption, suggesting abnormal mitochondrial function. Phalloidin staining of lateral line hair cells with and without UV treatment shows no difference in hair cell counts per neuromast between treatment groups. Mechanoelectrical transduction function after UV exposure, measured by FM1-43 uptake, is reduced. Metronidazole lethality is reduced, oxygen consumption rates are restored, and mechanoelectrical transduction function is preserved by treatment with Mn(III)tetrakis(4-benzoic acid)porphyrin Chloride (MnTBAP), a superoxide dismutase mimetic. We propose that defective mitochondrial function and increased reactive oxygen species levels provide a mechanism for hair cell dysfunction in this model of Cockayne Syndrome. These results provide a foundation for further experiments to explore disease mechanisms and treatment modalities for this premature aging condition.

#3

Mechanisms of transcription-coupled repair and DNA damage surveillance in health and disease.

Nature reviews. Molecular cell biology2026 Mar

RNA polymerase II (Pol II)-mediated gene transcription is frequently disrupted by DNA damage from various sources. Transcription-blocking DNA lesions hinder the progression of elongating Pol II, leading to transcription stress that, if unresolved, causes cellular dysfunction, neurodegeneration and ageing. In this Review, we discuss how different types of lesion are recognized by obstructing Pol II and removed by the intricate transcription-coupled nucleotide excision repair (TC-NER) pathway, emphasizing recent structural findings that reveal key aspects of the TC-NER mechanism. We also discuss the mechanisms proposed for processing lesion-stalled Pol II, which is crucial to facilitate TC-NER, and focus on how Pol II ubiquitylation orchestrates repair-complex assembly and Pol II degradation. In addition, we discuss the alternative mechanism of transcription-coupled DNA-protein crosslink repair, which was recently identified to be important for resolving DNA-protein crosslinks in active genes. Finally, we describe how these insights elucidate the different pathological causes of hereditary TC-NER deficiencies, namely of the mild cutaneous ultraviolet-sensitive syndrome and the severe progeroid Cockayne syndrome.

#4

Metronidazole-Induced Hepatotoxicity in Children with Cockayne Syndrome.

Indian journal of pediatrics2026 Feb
#5

[Cockayne syndrome: peculiarities of clinical manifestations and algorithm of observation in childhood].

Problemy endokrinologii2026 Mar 07

 Cockayne syndrome is an ultra-rare (1:2.5 million) hereditary disease from the group of progeroid syndromes caused by pathogenic and probable-pathogenic variants in DNA repair genes (ERCC8, ERCC6, XPB (ERCC3), XPD (ERCC2) and XPG (ERCC5)) and characterized by abnormal photosensitivity, congenital cataract, microcephaly, sensorineural hearing loss, nervous system pathology and other multisystem changes. In this manuscript, for the first time in the Russian Federation, we present the results of a clinical and genetic study and follow-up of a Russian cohort of patients.  During 2 years, from 2023 to 2025, 7 patients with Cockayne syndrome (4 girls and 3 boys) aged from 3 years 11 months to 16 years 3 months were under clinical observation, of whom 3 patients were diagnosed with Cockayne syndrome type A (causative variants in ERCC8 gene) and 4 patients with type B (causative variants in ERCC6 gene). All patients underwent a comprehensive multidisciplinary examination with evaluation of the results of laboratory and instrumental methods of investigation.  Based on observational data, we confirmed the incomplete correlation between genotype and phenotype previously described in the literature. With the genotype of Cockayne syndrome type B, previously correlated with severe course of the disease, only one patient had a severe course of the syndrome, two patients had a moderate course, and one patient had a mild course, indicating the variability of the clinical picture within a single gene lesion, and the severity of the course correlated rather with the age of the disease debut: early onset (before 1 year of age) was associated with faster disease progression. Also, regardless of the genotype and severity of the disease course, major diagnostic criteria were identified in all patients: congenital cataract was diagnosed in 5 of 7 observed patients, sensorineural hearing loss in two patients of moderate and mild course of the disease, progressive pathology of the nervous system in 6 of 7 patients, and microcephaly was diagnosed in all patients.  This study expands our understanding of the natural course of Cockayne syndrome and our knowledge of the variability of clinical manifestations and severity of the disease course within a single gene lesion. Timely diagnosis and personalized approach of a multidisciplinary team of specialists can slow the progression of complications and improve the quality of life of patients. The work is of value for physicians of various specialties involved in the diagnosis and treatment of orphan genetic diseases, as well as researchers studying the mechanisms of DNA repair and premature aging. ОБОСНОВАНИЕ. Синдром Коккейна — ультраредкое (1:2,5 млн) наследственное заболевание из группы прогероидных синдромов, обусловленное патогенными и вероятнопатогенными вариантами в генах репарации ДНК (ERCC8, ERCC6, XPB (ERCC3), XPD (ERCC2) и XPG (ERCC5)) и характеризующееся аномальной фоточувствительностью, врожденной катарактой, микроцефалией, нейросенсорной тугоухостью, патологией нервной системы и другими мультисистемными изменениями. В данной рукописи, впервые в Российской Федерации, представлены результаты клинико-генетического исследования и наблюдения за российской когортой пациентов. МАТЕРИАЛЫ И МЕТОДЫ. В течение 2 лет, с 2023 по 2025 гг., под клиническим наблюдением находились 7 пациентов с синдромом Коккейна (4 девочки и 3 мальчика) в возрасте от 3 лет 11 месяцев до 16 лет 3 месяцев, из них у 3 пациентов был диагностирован синдром Коккейна типа А (причинные варианты в гене ERCC8), у 4 пациентов — тип В (причинные варианты в гене ERCC6). Всем пациентам проводилось комплексное мультидисциплинарное обследование с оценкой результатов лабораторных и инструментальных методов исследования. РЕЗУЛЬТАТЫ. По данным наблюдений, нами подтверждена неполная корреляция между генотипом и фенотипом, описанная ранее в литературе. При генотипе синдрома Коккейна типа В, ранее коррелирующего с тяжелым течением заболевания, только у одного пациента наблюдалось тяжелое течение синдрома, у двух — умеренной степени, у одного пациента — легкое течение, что свидетельствует о вариабельности клинической картины в рамках поражения одного гена, а тяжесть течения коррелировала скорее с возрастом дебюта заболевания: раннее начало (до 1 года) ассоциировалось с более быстрым прогрессированием заболевания. Также, вне зависимости от генотипа и степени тяжести течения заболевания, большие диагностические критерии были выявлены у всех пациентов: врожденная катаракта была диагностирована у 5 из 7 наблюдаемых пациентов, нейросенсорная тугоухость — у двух пациентов умеренного и легкого течения заболевания, прогрессирующая патология нервной системы — у 6 пациентов из 7, микроцефалия была диагностирована у всех пациентов. ЗАКЛЮЧЕНИЕ. Проведенное исследование расширяет понимание естественного течения синдрома Коккейна и наши знания о вариабельности клинических проявлений и тяжести течения заболевания в рамках поражения одного гена. Своевременная диагностика и персонализированный подход мультидисциплинарной команды специалистов способны замедлить прогрессирование осложнений и улучшить качество жизни пациентов. Работа представляет ценность для врачей различных специальностей, занимающихся диагностикой и лечением орфанных генетических заболеваний, а также исследователей, изучающих механизмы репарации ДНК и преждевременное старение.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC606 artigos no totalmostrando 196

2026

[Cockayne syndrome: peculiarities of clinical manifestations and algorithm of observation in childhood].

Problemy endokrinologii
2026

A Robust Methodological Framework for Generating Whole-Brain and Cortical Organoids From Diverse Healthy- and Patient-Derived Induced Pluripotent Stem Cell Lines.

Biology of the cell
2026

Repurposing Alkylating Agents in Melanoma via ERCC8 Silencing: A Novel Therapeutic Strategy.

Cancers
2026

Swallowing and Communication in Cockayne Syndrome: Clinical Characteristics and Management.

American journal of medical genetics. Part A
2025

Studies on the functionality of the TC-NER ERCC6-M1097V protein variant frequently found in Louisiana patients with PCa upon UV damage.

Frontiers in oncology
2026

Advancing Obstetric Care: The Role of Targeted Next-Generation Sequencing in Pregnancies with Structurally Normal Fetuses.

Journal of the Chinese Medical Association : JCMA
2026

Cockayne syndrome mutation in XPG activate the integrated stress response.

Human genetics
2026

ercc6 deficient zebrafish exhibit UV and metronidazole sensitivity, increased oxygen consumption, and impaired hair cell mechanoelectrical transduction which can be restored by the superoxide dismutase mimetic MnTBAP.

Human molecular genetics
2026

Genotype-phenotype associations in a robust cohort of 69 patients with xeroderma pigmentosum across Türkiye: a multicentre study.

The British journal of dermatology
2025

A Truncating Variant in the ERCC6 Gene With Three Different Phenotypes: Significant Effects of Modifier Genes.

Genetics research
2025

PARP1 and PARylation facilitate transcription-coupled DNA repair by stabilizing the CSB-RNAPII complex.

Nucleic acids research
2026

Metronidazole-Induced Hepatotoxicity in Children with Cockayne Syndrome.

Indian journal of pediatrics
2025

Molecular basis for CSB stimulation of the SNM1A DNA repair nuclease.

Research square
2025

Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study.

PloS one
2025

Clinical and molecular genetic analysis of a Chinese patient with Cockayne syndrome caused by ERCC8 gene synonymous variant at splicing site and exon 1 deletion.

Orphanet journal of rare diseases
2026

Mechanisms of transcription-coupled repair and DNA damage surveillance in health and disease.

Nature reviews. Molecular cell biology
2025

Expanding the landscape of nucleotide excision repair disorders: from discovery to therapy.

The Journal of clinical investigation
2025

Protective role of Cockayne Syndrome B (CSB) protein in maintaining genome integrity in human cells under oxidative stress.

Mutation research. Genetic toxicology and environmental mutagenesis
2025

Expert Consensus on Genetic Diagnostic Approaches for Patients With Limb-Girdle Muscular Dystrophy.

Neurology
2025

Exploring the interaction between nucleotide excision repair pathways and Huntington disease: Implications for neurodegeneration and phenotypic overlap.

Parkinsonism & related disorders
2026

Overexpression of Ku80 Protects Lens Epithelial Cells from Selenium-Induced Cataract Formation by Regulating the DNA Damage Response.

Current eye research
2025

Case report: neuroimaging in Cockayne syndrome.

Radiology case reports
2025

Neuroimages of an Adult Cockayne Syndrome Patient.

Internal medicine (Tokyo, Japan)
2025

The aflatoxin B1-induced formamidopyrimidine adduct is repaired by transcription-coupled nucleotide excision repair in human cells.

NAR cancer
2025

Anaesthesia for children with DNA repair disorders.

BJA education
2025

Clinical and genetic analysis of ERCC8-Related cockayne syndrome: hepatic dysfunction as a biomarker, anhidrosis as a rare feature, and rehabilitation outcomes for ankle contractures.

Frontiers in genetics
2025

Genome-wide mapping of formaldehyde-induced DNA-protein crosslinks reveals unique patterns of formation and transcription-coupled removal in mammalian cells.

Nucleic acids research
2025

Transcription-Coupled Nucleotide Excision Repair: A Faster Solution or the Only Option?

Biomolecules
2025

Unusual Blood Pressure Response to Local Anesthetic in a Patient With Rare Cockayne Syndrome Undergoing Dental Surgery Under General Anesthesia.

Paediatric anaesthesia
2024

The clinical spectrum associated with ERCC5 mutations: Is there a relationship between phenotype and genotype?

Pediatric discovery
2025

Altered pathways in Cockayne syndrome: Involvement of MAPK, PI3K-Akt, extracellular matrix, inflammation, and neuronal signaling.

DNA repair
2025

Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis?

Aging cell
2025

Cockayne syndrome B with axonal sensorimotor polyneuropathy caused by a de novo mutation of the gene ERCC6: A novel phenotypic and genotypic variant.

Neurologia
2025

The landscape of pediatric genetic white matter disorders at a tertiary referral hospital in Upper Egypt and the report of 31 novel variants.

Italian journal of pediatrics
2025

Emerging mechanisms underlying formaldehyde toxicity and response.

Molecular cell
2025

Biological Models of Oxidative Purine DNA Damage in Neurodegenerative Disorders.

Antioxidants (Basel, Switzerland)
2025

Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesis.

Cell death and differentiation
2025

Amy and Friends: improving the lives of individuals affected by DNA repair disorders.

FEBS letters
2025

Transcription-coupled repair: tangled up in convoluted repair.

The FEBS journal
2025

Clinical and molecular overlap between nucleotide excision repair (NER) disorders and DYRK1A haploinsufficiency syndrome.

Frontiers in neuroscience
2025

Transcription blocking properties and transcription-coupled repair of N2-alkylguanine adducts as a model for aldehyde-induced DNA damage.

The Journal of biological chemistry
2025

A rare variation of ERCC8 gene cause Cockayne syndrome in a Chinese family.

Frontiers in genetics
2025

ATP-Dependent Chromatin Remodeler CSB Couples DNA Repair Pathways to Transcription with Implications for Cockayne Syndrome and Cancer Therapy.

Cells
2025

Trichothiodystrophy due to ERCC2 Variants: Uncommon Contributor to Progressive Hypomyelinating Leukodystrophy.

Molecular genetics & genomic medicine
2025

The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.

International journal of molecular sciences
2024

PML Nuclear Bodies and Cellular Senescence: A Comparative Study of Healthy and Premature Aging Syndrome Donors' Cells.

Cells
2025

Syndromic retinitis pigmentosa.

Progress in retinal and eye research
2025

Activities of the Research Group for Comprehensive Research of Gene Mutation-related Rare and Intractable Diseases of the Skin within the Project for Research on Intractable Diseases of the Ministry of Health, Labor, and Welfare of Japan.

The Keio journal of medicine
2025

Transcription-coupled repair - mechanisms of action, regulation, and associated human disorders.

FEBS letters
2024

Reliability of high-quantity human brain organoids for modeling microcephaly, glioma invasion and drug screening.

Nature communications
2025

A subset of human dermal fibroblasts overexpressing Cockayne syndrome group B protein resist UVB radiation-mediated premature senescence.

Aging cell
2024

Homozygous Microdeletion Involving Exon 1 of ERCC8 and NDUFAF2 With Uniparental Isodisomy of Chromosome 5.

Molecular genetics & genomic medicine
2025

Transcription-coupled repair of DNA-protein crosslinks.

Trends in cell biology
2024

Supplementation with nicotinamide limits accelerated aging in affected individuals with cockayne syndrome and restores antioxidant defenses.

Aging
2024

The Emerging Roles of Multimolecular G-Quadruplexes in Transcriptional Regulation and Chromatin Organization.

Accounts of chemical research
2024

A mild case of Cockayne syndrome with a novel start-loss variant of ERCC8.

Human genome variation
2024

Preimplantation genetic testing for Cockayne syndrome with a novel ERCC6 variant in a Chinese family.

Frontiers in genetics
2024

Perspectives in the investigation of Cockayne syndrome group B neurological disease: the utility of patient-derived brain organoid models.

Journal of Zhejiang University. Science. B
2025

Cockayne syndrome B protein is implicated in transcription and associated chromatin dynamics in homeostatic and genotoxic conditions.

Aging cell
2024

Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair.

Nature communications
2024

Childhood-inherited white matter disorders with calcification.

Handbook of clinical neurology
2024

General loss of proteostasis links Huntington disease to Cockayne syndrome.

Neurobiology of disease
2024

Molecular insights into the stimulation of SNM1A nuclease activity by CSB during interstrand crosslink processing.

bioRxiv : the preprint server for biology
2024

A novel role for CSA in the regulation of nuclear envelope integrity: uncovering a non-canonical function.

Life science alliance
2024

Biallelic structural variants in three patients with ERCC8-related Cockayne syndrome and a potential pitfall of copy number variation analysis.

Scientific reports
2024

HiPSC-derived 3D neural models reveal neurodevelopmental pathomechanisms of the Cockayne Syndrome B.

Cellular and molecular life sciences : CMLS
2024

A Cockayne-Syndrome-Like Phenotype with a Homozygous Truncating UVSSA Variant: Might This Be a New Cause?

Molecular syndromology
2024

DNA lesions that block transcription induce the death of Trypanosoma cruzi via ATR activation, which is dependent on the presence of R-loops.

DNA repair
2024

Sequential post-translational modifications regulate damaged DNA-binding protein DDB2 function.

Journal of biochemistry
2024

Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity.

Nucleic acids research
2024

Cockayne Syndrome Linked to Elevated R-Loops Induced by Stalled RNA Polymerase II during Transcription Elongation.

Nature communications
2025

Genomic stress in diseases stemming from defects in the second brain.

Neurogastroenterology and motility
2024

CS proteins and ubiquitination: orchestrating DNA repair with transcription and cell division.

Trends in cell biology
2024

Distinct DNA repair mechanisms prevent formaldehyde toxicity during development, reproduction and aging.

Nucleic acids research
2024

The ARK2N-CK2 complex initiates transcription-coupled repair through enhancing the interaction of CSB with lesion-stalled RNAPII.

Proceedings of the National Academy of Sciences of the United States of America
2024

Cognitive Decline and Other Late-Stage Neurologic Complications in Cockayne Syndrome.

Neurology. Clinical practice
2024

Treatment outcomes of cochlear implantation in pediatric patients with Cockayne syndrome type I: a case series.

Journal of surgical case reports
2024

Spectrum of ERCC6-Related Cockayne Syndrome (Type B): From Mild to Severe Forms.

Genes
2024

Airway management in a patient with Cockayne syndrome.

Anaesthesia reports
2024

DNA repair deficiencies and neurodegeneration.

DNA repair
2024

Cockayne Syndrome Patient iPSC-Derived Brain Organoids and Neurospheres Show Early Transcriptional Dysregulation of Biological Processes Associated with Brain Development and Metabolism.

Cells
2024

Transcription-coupled repair of DNA-protein cross-links depends on CSA and CSB.

Nature cell biology
2024

Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair.

Nature cell biology
2023

Premature aging in genetic diseases: what conclusions can be drawn for physiological aging.

Frontiers in aging
2024

Immunity in the Progeroid Model of Cockayne Syndrome: Biomarkers of Pathological Aging.

Cells
2024

Preimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study.

Journal of assisted reproduction and genetics
2024

CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells.

Nucleic acids research
2024

A compound heterozygous mutation of ERCC8 is responsible for a family with Cockayne syndrome.

Molecular biology reports
2024

Mitochondrial DNA integrity and metabolome profile are preserved in the human induced pluripotent stem cell reference line KOLF2.1J.

Stem cell reports
2024

Generation of site-specifically labelled fluorescent human XPA to investigate DNA binding dynamics during nucleotide excision repair.

Methods (San Diego, Calif.)
2024

Defining the progeria phenome.

Aging
2024

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

The Lancet. Child & adolescent health
2024

Magnetic Bimetallic Heterointerface Nanomissiles with Enhanced Microwave Absorption for Microwave Thermal/Dynamics Therapy of Breast Cancer.

ACS nano
2024

A Novel Heterozygous De Novo MORC2 Missense Variant Causes an Early Onset and Severe Neurodevelopmental Disorder.

Case reports in genetics
2024

Elf1 promotes Rad26's interaction with lesion-arrested Pol II for transcription-coupled repair.

Proceedings of the National Academy of Sciences of the United States of America
2024

Cockayne syndrome: A pediatric neurodegenerative disorder linking mitochondria to aging.

Journal of the neurological sciences
2024

Live-cell imaging of endogenous CSB-mScarletI as a sensitive marker for DNA-damage-induced transcription stress.

Cell reports methods
2023

A Case of ERCC6-Related Cockayne Syndrome Presenting with Levodopa-Responsive Tremor Syndrome.

Movement disorders clinical practice
2024

Constructing green superhydrophilic and superoleophobic COFs-MOFs hybrid-based membrane for efficiently emulsion separation and synchronous removal of microplastics, dyes, and pesticides.

Environmental research
2023

TFIIH central activity in nucleotide excision repair to prevent disease.

DNA repair
2023

Mixed-Linkage Donor-Acceptor Covalent Organic Framework as a Turn-On Fluorescent Sensor for Aliphatic Amines.

Analytical chemistry
2023

Heat shock protein DNAJA2 regulates transcription-coupled repair by triggering CSB degradation via chaperone-mediated autophagy.

Cell discovery
2024

Genome-wide analysis of transcription-coupled repair reveals novel transcription events in Caenorhabditis elegans.

bioRxiv : the preprint server for biology
2023

Characterisation of a novel missense mutation in the ERCC5 gene leading to group G xeroderma pigmentosum/Cockayne syndrome overlap.

BMJ case reports
2024

Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes.

GeroScience
2023

Epigenomic signature of accelerated ageing in progeroid Cockayne syndrome.

Aging cell
2023

Recent advances in fluorescence-based chemosensing of organoarsenic feed additives using luminescence MOFs, COFs, HOFs, and QDs.

Chemical communications (Cambridge, England)
2023

Efficient capture and highly sensitive analysis of okadaic acid by three-dimensional covalent organic frameworks with hydroxyl surface engineering.

Journal of chromatography. A
2023

[Progeroid syndromes : Aging, skin aging, and mechanisms of progeroid syndromes].

Dermatologie (Heidelberg, Germany)
2023

Cockayne syndrome type 3 with dystonia-ataxia and clicking blinks.

Movement disorders clinical practice
2023

Arabidopsis RAD16 Homologues Are Involved in UV Tolerance and Growth.

Genes
2023

Next-generation sequencing through multi-gene panel testing for the diagnosis of a Chinese patient with atypical Cockayne syndrome.

Molecular genetics & genomic medicine
2023

CSB Regulates Pathway Choice in Response to DNA Replication Stress Induced by Camptothecin.

International journal of molecular sciences
2023

The Multifaceted Syndromic Primary Immunodeficiencies in Children.

Journal of clinical medicine
2023

Insights into aging from progeroid syndrome epigenetics.

Aging
2024

The role of Transcription Factor IIH complex in nucleotide excision repair.

Environmental and molecular mutagenesis
2023

Siblings with Cockayne Syndrome B Type III Presenting with Slowly Progressive Cerebellar Ataxia.

Internal medicine (Tokyo, Japan)
2023

Size-controlling preparation of covalent organic framework nanospheres for electrochemical impedimetric aptasensing of oxytetracycline.

Talanta
2023

Aldehyde-Associated Mutagenesis─Current State of Knowledge.

Chemical research in toxicology
2023

Orally delivered 2D covalent organic frameworks releasing kynurenine generate anti-inflammatory T cell responses in collagen induced arthritis mouse model.

Biomaterials
2023

The CSB chromatin remodeler regulates PARP1- and PARP2-mediated single-strand break repair at actively transcribed DNA regions.

Nucleic acids research
2023

Cockayne syndrome group A protein localizes at centrosomes during mitosis and regulates Cyclin B1 ubiquitination.

European journal of cell biology
2023

The nucleotide excision repair proteins through the lens of molecular dynamics simulations.

DNA repair
2023

Atypical features in two adult patients with Cockayne syndrome and analysis of genotype-phenotype correlation.

Chinese medical journal
2023

Transcription-Coupled Nucleotide Excision Repair and the Transcriptional Response to UV-Induced DNA Damage.

Annual review of biochemistry
2023

Can accelerated ageing models inform us on age-related tauopathies?

Aging cell
2023

Age or lifestyle-induced accumulation of genotoxicity is associated with a length-dependent decrease in gene expression.

iScience
2023

Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders.

Biomolecules
2023

Reticular Chemistry-Enabled Sonodynamic Activity of Covalent Organic Frameworks for Nanodynamic Cancer Therapy.

Angewandte Chemie (International ed. in English)
2023

Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases.

IBRO neuroscience reports
2023

Case report: Variants in the ERCC4 gene as a rare cause of cerebellar ataxia with chorea.

Frontiers in genetics
2023

The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome.

Pediatric neurology
2023

Three-Dimensional van der Waals Heterostructure-Based Nanocages as Supersensitive 3-Hydroxy-2-butanone Gas Sensors at Room Temperature.

ACS sensors
2023

A case of Cockayne syndrome with unusually mild clinical manifestations.

The Journal of dermatology
2023

Identification and characterization of Necdin as a target for the Cockayne syndrome B protein in promoting neuronal differentiation and maintenance.

Pharmacological research
2022

An ionic vinylene-linked three-dimensional covalent organic framework for selective and efficient trapping of ReO4- or 99TcO4.

Nature communications
2023

Novel Presentation of Hemiplegic Migraine in a Patient With Cockayne Syndrome.

Pediatric neurology
2022

Aicardi-Goutières syndrome with SAMHD1 deficiency can be diagnosed by unscheduled DNA synthesis test.

Frontiers in pediatrics
2023

Fluorine-Containing Covalent Organic Frameworks: Synthesis and Application.

Macromolecular rapid communications
2022

Assessing the Formation of Purine Lesions in Mitochondrial DNA of Cockayne Syndrome Cells.

Biomolecules
2023

TFIIH mutations can impact on translational fidelity of the ribosome.

Human molecular genetics
2022

A Novel Missense Mutation in ERCC8 Co-Segregates with Cerebellar Ataxia in a Consanguineous Pakistani Family.

Cells
2022

Prevalence and mechanisms of somatic deletions in single human neurons during normal aging and in DNA repair disorders.

Nature communications
2023

Peripheral neuropathies associated with DNA repair disorders.

Muscle & nerve
2022

Role of Cockayne Syndrome Group B Protein in Replication Stress: Implications for Cancer Therapy.

International journal of molecular sciences
2022

The ATRX splicing variant c.21-1G>A is asymptomatic.

Human genome variation
2022

Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology.

International journal of molecular sciences
2022

LINE-1 RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes.

Science translational medicine
2022

Clinical, immunological, and genetic investigations in a rare association of type 1 diabetes with xeroderma pigmentosum.

Pediatric endocrinology, diabetes, and metabolism
2022

A matter of delicate balance: Loss and gain of Cockayne syndrome proteins in premature aging and cancer.

Frontiers in aging
2022

A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders.

Neurogenetics
2022

A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.

PloS one
2022

Cockayne syndrome without UV-sensitivity in Vietnamese siblings with novel ERCC8 variants.

Aging
2022

Cockayne syndrome group B protein uses its DNA translocase activity to promote mitotic DNA synthesis.

DNA repair
2022

Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERDND ): Time to Move Beyond the Skin.

Movement disorders : official journal of the Movement Disorder Society
2022

Whole-exome sequencing revealed a novel ERCC6 variant in a Vietnamese patient with Cockayne syndrome.

Human genome variation
2024

Whole exome sequencing identifies a novel variant causing cockayne syndrome type I in a consanguineous Pakistani family.

The International journal of neuroscience
2022

Metronidazole-induced hepatotoxicity in a patient with xeroderma pigmentosum: A case report.

Medicine
2022

Keeping COFs in the loop.

Nature chemistry
2022

Radiotherapy and radiosensitivity syndromes in DNA repair gene mutations.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2022

Effects of Oxygen Tension for Membrane Lipidome Remodeling of Cockayne Syndrome Cell Models.

Cells
2022

CSA Antisense Targeting Enhances Anticancer Drug Sensitivity in Breast Cancer Cells, including the Triple-Negative Subtype.

Cancers
2022

Camptothecin compromises transcription recovery and cell survival against cisplatin and ultraviolet irradiation regardless of transcription-coupled nucleotide excision repair.

DNA repair
2022

The UVSSA protein is part of a genome integrity homeostasis network with links to transcription-coupled DNA repair and ATM signaling.

Proceedings of the National Academy of Sciences of the United States of America
2022

Statistical Approach of the Role of the Conserved CSB-PiggyBac Transposase Fusion Protein (CSB-PGBD3) in Genotype-Phenotype Correlation in Cockayne Syndrome Type B.

Frontiers in genetics
2022

Heterogeneous clinical features in Cockayne syndrome patients and siblings carrying the same CSA mutations.

Orphanet journal of rare diseases
2022

XPG: a multitasking genome caretaker.

Cellular and molecular life sciences : CMLS
2022

Dynamic Interplay between Cockayne Syndrome Protein B and Poly(ADP-Ribose) Polymerase 1 during Oxidative DNA Damage Repair.

Biomedicines
2022

Kidneys control inter-organ homeostasis.

Nature reviews. Nephrology
2022

Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.

Proceedings of the National Academy of Sciences of the United States of America
2022

Very early prenatal diagnosis of Cockayne's syndrome by coelocentesis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2021

Identification and Characterization of a Novel Recurrent ERCC6 Variant in Patients with a Severe Form of Cockayne Syndrome B.

Genes
2022

Embryonal sarcoma of the liver in a girl with Cockayne syndrome.

Clinical genetics
2021

Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells.

Nucleic acids research
2021

Cockayne Syndrome B Protein Selectively Resolves and Interact with Intermolecular DNA G-Quadruplex Structures.

Journal of the American Chemical Society
2021

Mechanism of Rad26-assisted rescue of stalled RNA polymerase II in transcription-coupled repair.

Nature communications
2021

Whole Exome Sequencing Identifies a Novel Homozygous Missense Mutation in the CSB Protein-Encoding ERCC6 Gene in a Taiwanese Boy with Cockayne Syndrome.

Life (Basel, Switzerland)
2021

Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response.

Nature
2022

Hepatotoxicity of metronidazole in Cockayne syndrome: A clinical report.

European journal of medical genetics
2021

Functions of the CSB Protein at Topoisomerase 2 Inhibitors-Induced DNA Lesions.

Frontiers in cell and developmental biology
2021

Cockayne syndrome type: a very rare association with hemorrhagic stroke.

The Turkish journal of pediatrics
2022

Deep Brain Stimulation for Cockayne Syndrome-Associated Movement Disorder.

Journal of movement disorders
2021

Neurovascular dysfunction and neuroinflammation in a Cockayne syndrome mouse model.

Aging
2021

Metronidazole-Induced Hepatitis in a Teenager With Xeroderma Pigmentosum and Trichothiodystrophy Overlap.

Pediatrics
2021

Cockayne syndrome group A and ferrochelatase finely tune ribosomal gene transcription and its response to UV irradiation.

Nucleic acids research
2021

Neuroblastoma Cells Depend on CSB for Faithful Execution of Cytokinesis and Survival.

International journal of molecular sciences
2021

Structural basis of human transcription-DNA repair coupling.

Nature
2021

Identification of two novel homozygous mutations in ERCC8 gene in two unrelated consanguineous families with Cockayne syndrome from Iran.

Clinica chimica acta; international journal of clinical chemistry
2022

Reactive Species in Progeroid Syndromes and Aging-Related Processes.

Antioxidants & redox signaling
2021

Transcription-coupled repair and the transcriptional response to UV-Irradiation.

DNA repair
2021

Genetic Diagnosis in Children with Epilepsy and Developmental Disorders by Targeted Gene Panel Analysis in a Developing Country.

Journal of epilepsy research
2021

50 Years Ago in TheJournalofPediatrics: Cataracts, Microcephaly, and Arthrogryposis.

The Journal of pediatrics
2021

DRP1 Inhibition Rescues Mitochondrial Integrity and Excessive Apoptosis in CS-A Disease Cell Models.

International journal of molecular sciences
2021

Generation of an induced pluripotent stem cell line (IUFi001) from a Cockayne syndrome patient carrying a mutation in the ERCC6 gene.

Stem cell research
2021

Botulinum toxin injection for Cockayne syndrome with muscle spasticity over bilateral lower limbs: A case report.

World journal of clinical cases
2021

Cockayne Syndrome-Associated CSA and CSB Mutations Impair Ribosome Biogenesis, Ribosomal Protein Stability, and Global Protein Folding.

Cells
Ver todos os 606 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Cockayne tipo 2.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Cockayne tipo 2

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Robust Methodological Framework for Generating Whole-Brain and Cortical Organoids From Diverse Healthy- and Patient-Derived Induced Pluripotent Stem Cell Lines.
    Biology of the cell· 2026· PMID 41761927mais citado
  2. ercc6 deficient zebrafish exhibit UV and metronidazole sensitivity, increased oxygen consumption, and impaired hair cell mechanoelectrical transduction which can be restored by the superoxide dismutase mimetic MnTBAP.
    Human molecular genetics· 2026· PMID 41527836mais citado
  3. Mechanisms of transcription-coupled repair and DNA damage surveillance in health and disease.
    Nature reviews. Molecular cell biology· 2026· PMID 41254380mais citado
  4. Metronidazole-Induced Hepatotoxicity in Children with Cockayne Syndrome.
    Indian journal of pediatrics· 2026· PMID 41354724mais citado
  5. [Cockayne syndrome: peculiarities of clinical manifestations and algorithm of observation in childhood].
    Problemy endokrinologii· 2026· PMID 41834603mais citado
  6. The role of transcription-coupled nucleotide excision repair (TC-NER) during mammalian forebrain development.
    Dev Biol· 2026· PMID 41921730recente
  7. Integrating Structural, Biochemical, and Cellular Perspectives on the TFIIH Helicases XPB and XPD.
    Biomolecules· 2026· PMID 41897370recente
  8. Repurposing Alkylating Agents in Melanoma via ERCC8 Silencing: A Novel Therapeutic Strategy.
    Cancers (Basel)· 2026· PMID 41749901recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90322(Orphanet)
  2. OMIM OMIM:133540(OMIM)
  3. MONDO:0019570(MONDO)
  4. GARD:1420(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q914389(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Cockayne tipo 2
Compêndio · Raras BR

Síndrome Cockayne tipo 2

ORPHA:90322 · MONDO:0019570
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Início
Antenatal, Infancy, Neonatal
MedGen
UMLS
C0009207
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades